Search results
Recurrent Cutaneous Manifestation in Multiple Myeloma. Mariam Hina, Saad Salim Naviwala, Munira Shabbir-Moosajee, Nasir Ali. 6 August 2024. Resolution of a chronic occipital wound with exposed skull bone with a fish skin graft: a successful treatment approach.
Tracheal airway obstruction induced by a large glomangioma: discussion of management and literature review. Bassel Hallak, Stephane Yerly, Salim Bouayed, Lynda Zidi. BMJ Case Reports CP Sep 2024, 17 (9) e261481; DOI: 10.1136/bcr-2024-261481. Unresectable squamous cell carcinoma in a patient with spina bifida.
30 paź 2023 · Margin status was clear (≥2 mm) in 81% of women, involved (<2 mm) in 5%, and missing in 14%. The 10 year cumulative incidence of ipsilateral invasive breast cancer and ipsilateral DCIS was 3.2% and 1.8%, respectively.
20 kwi 2023 · BMJ Oncology aims to improve cancer outcomes by: Publishing a broad range of peer-reviewed articles that provide significant clinical, scientific and educational value. Reaching a wide international audience through BMJ’s global recognition and clinical following.
10 maj 2024 · The role of artificial intelligence (AI) in cancer care has evolved in the face of ageing population, workforce shortages and technological advancement. Despite recent uptake in AI research and adoption, the extent to which it improves quality, efficiency and equity of care beyond cancer diagnostics is uncertain to date.
20 sie 2024 · Precision oncology is transforming cancer care, particularly for advanced, treatment resistant cases, but the clinical importance of many genetic alterations remains uncertain. The evidence base underlying National Comprehensive Cancer Network (NCCN) recommendations can vary widely across different cancers
Mirvetuximab soravtansine-gynx (MIRV) is a conjugate of a folate receptor alpha (FRα)-directed antibody and the maytansinoid microtubule inhibitor, DM4. Accumulating pre-clinical and clinical data supported the safety and anti-tumor activity of MIRV in tumors expressing FRα.
